Sign in
4

Changes in Ownership

Viskase Holdings, Inc. Filed Acc 0000930413-11-007260

VP, Clinical Development sold 2,700 shares at $7.06 ($19,062)

From the SEC's structured data for this filing

Trades in this filing

Buchbinder Aby · VP, Clinical Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2011-11-08 Sale : show line 1 in the form −2,700 $7.06 $19,062 54,015 D
Open-market sales · 2,700 sh · avg $7.06 · $19,062
Loading xslF345X03/c67539_4.xml…